VCEL Reports $12.4M Revenue, $0.08 EPS, +15% YoY, Approves $150M Buyback, Ratifies PwC as Auditor
Vericel Corporation · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $32.82
-7.4% in 7d after detection
Post-detection moves
1h
—
1d
+2.6%
3d
+3.4%
7d
-7.4%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS